期刊文献+

OX40-OX40L在人单核细胞和冠脉斑块中的共同表达 被引量:2

Coexpression of OX40 and OX40 ligand on human monocytes and in coronary atherosclerotic plaque lesions
原文传递
导出
摘要 目的探讨细胞刺激分子OX40及其配体OX40L在人单核细胞及冠状动脉粥样硬化斑块(冠脉斑块)中的表达。方法采用荧光技术、流式细胞术检测OX40、OX40L在单核细胞表面的表达,免疫组化方法检测在冠脉斑块中的表达。结果 OX40、OX40L在人单核细胞能连续表达,且细胞因子IL-1β、IL-6、TNF-α和INF-γ能明显刺激其表达;冠脉斑块中能共同表达OX40L(肩部和底部)和OX40(广泛),而动脉壁其它部分不表达。结论人单核细胞表面及冠脉斑块中能共同高表达OX40和OX40L。 Objective To investigate the coexpression of OX40 and OX40 and its ligand (OX40L) on human monocytes and in coronary atherosclerotic plaque lesions.Methods The expressions of OX40 and OX40L on human monocytes were measured by fluorescence microscope and flow cytometry,respectively.The expressions OX40 and OX40L in atheroma plaques were detected by immunohistochemistry.Results Cultured human monocytes continuously coexpressed OX40 and OX40L on the surface of the cells.Stimulation with interleukin(IL)-1β,IL-6,tumor necrosis factor(TNF)-α and interferon-Υ increased the levels of OX40 and OX40L on monocytes.Human coronary atherosclerotic lesions showed the coexpressions of immunoreactive OX40 and OX40L.OX40L mainly expressed on the shoulder and base of the plaque,but OX40 was widespreadly expressed in the plaque.There were no expressions of OX40 and OX40L in nonatherosclerotic human arteries.ConclusionOX40 and OX40L could coexpress on the surface of human monocytes and in human atherosclerotic plaque lesions.
出处 《江苏医药》 CAS CSCD 北大核心 2010年第10期1175-1177,F0003,共4页 Jiangsu Medical Journal
基金 江苏省科教兴卫工程(RC2007033) 镇江市社会发展项目资助(SH2007020)
关键词 OX40 OX40配体 动脉粥样硬化 单核细胞 OX40 OX40 ligand Atherosclerosis Monocytes
  • 相关文献

参考文献7

  • 1Kumanogoh A,Wang X, Lee I, et al. Increase T cell autoreactivity in the absence of OX40 OX40L ligand interaction:a role of OX40 in regulatory T cell development[J].J Immunol, 2001,166(1) :353-360.
  • 2Wang X,Ria M,Kelmenson PM,et al. Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility[J]. Nat Genet, 2005,4(37) : 365- 372.
  • 3Ria M, Eriksson P, Boquist S, et al. Human genetic evidence that OX40 is implicated in myocardial infarction[J]. Biochem Biophys Res Commun,2006,339(3): 1001-1006.
  • 4Liu DM, Yan JC,Wang CP, et at. The clinical implications of increased OX40 ligand expression in patients with acute coronary syndrome[J]. Clin Chim Acta,2008,397(1-2) :22-26.
  • 5Sugiyama S, Okada Y, Sukhova GK, et al. Macrophage myeloperoxidase regulation by granulocyte macrophage colonystimulating factor in human atherosclerosis and implications in acute coronary syndromes[J]. Am J Pathol, 2001,158(3) : 879- 891.
  • 6严金川,陈广华,王翠平,赵建伟,杜荣增,刘培晶.急性冠脉综合征患者OX40配体表达的变化[J].中国病理生理杂志,2009,25(8):1491-1494. 被引量:1
  • 7Wang YH, Liu YJ. OX40-OX40L interactions: a promising therapeutic target for allergic diseases [J]? J Clin Invest, 2007,117(12) :3655-3657.

二级参考文献7

  • 1Wang X, Ria M, Kelmenson PM, et al. Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility [ J ]. Nat Genet, 2005, 4(37):365 -372.
  • 2Ria M, Eriksson P, Boquist S, et al. Human genetic evidence that OX40 is implicated in myocardial infarction [J]. Biochem Biophys Res Commun, 2006, 339(3): 1001 - 1006.
  • 3Croft M. Co - stimulatory members of the TNFR family: keys to effective T -cell immunity? [ J]. Nat Rev Immunol, 2003, 3 (2) :609 - 620.
  • 4Imura A, Hori T, Imada T, et al. The human OX40/ gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells [ J ]. J Exp Med, 1996, 183(5) :2185 -2195.
  • 5Sugamura K, Ishii N, Weinberg AD. Therapeutic targeting if the effector T - cell co - stimulatory molecule OX40 [J]. Nat Rev Immunol, 2004, 4(12) :420 -431.
  • 6Smith J. Quantitative trait locus mapping for atherosclerosis susceptibility [ J ]. Curt Opin Lipidol, 2003, 14 (5) : 499 - 503.
  • 7吴连拼,官学强,黄明远,唐疾飞,杨鹏麟.急性冠脉综合征患者pentraxin-3与纤维蛋白原的变化[J].中国病理生理杂志,2008,24(5):1028-1029. 被引量:4

同被引文献6

  • 1Macian F. NFAT proteins: key regulators of T-cell develop- ment and function[J]. Nat Rev Immunol, 2005,5 (6) : 472-484.
  • 2Sieber M, Baurngrass R.Novel inhibitors of the calcineurin/ NFATc hub-alternatives to CsA and FK506[J]? Cell Commun Signal,2009,7(1) :25.
  • 3Zadelaar AS, yon der Thiisen JH, Boesten LS, et al. Increased vulnerability of pre-existing atherosclerosis in ApoE-deficient mice following adenovirus-mediated Fas ligand gene transfer [J]. Atherosclerosis, 2005,183 (2): 244-250.
  • 4Gotsman I, Sharpe AH, Lichtman AH. T-cell costimulation and coinhibition in atherosclerosis [ J ]. Circ Res, 2008, 103 ( 11 ) : 1220-1231.
  • 5Yan J, Wang C, Du R, et al. OX40-OX40 ligand interaction may activate phospholipase C signal transduction pathway in human umbilical vein endothelial cells [J ]. Chem Biol Interact, 2009, 180(3) : 460-464.
  • 6Karpurapu M, Wang D, Singh NK, et al. NFATcl targets cyclin A in the regulation of vascular smooth muscle cell multi- plication during restenosis[J].J Biol Chem, 2008, 283 (39):26577-26590.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部